175 related articles for article (PubMed ID: 1951410)
1. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.
Rousey SR; Russler S; Gottlieb M; Ash RC
Am J Med; 1991 Nov; 91(5):484-92. PubMed ID: 1951410
[TBL] [Abstract][Full Text] [Related]
2. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
6. 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Ussetti P; Solé J; Gavaldá J; Roman A
Transpl Int; 2016 Jan; 29(1):51-62. PubMed ID: 26339864
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.
Myers SE; Devine SM; Topper RL; Ondrey M; Chandler C; O'Toole K; Williams SF; Larson RA; Geller RB
Leuk Lymphoma; 1992 Oct; 8(3):229-33. PubMed ID: 1490149
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.
Hertenstein B; Kern WV; Schmeiser T; Stefanic M; Bunjes D; Wiesneth M; Novotny J; Heimpel H; Arnold R
Ann Hematol; 1994 Jan; 68(1):21-6. PubMed ID: 8110874
[TBL] [Abstract][Full Text] [Related]
9. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
10. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
O'Donnell MR; Schmidt GM; Tegtmeier BR; Faucett C; Fahey JL; Ito J; Nademanee A; Niland J; Parker P; Smith EP
J Clin Oncol; 1994 Apr; 12(4):827-34. PubMed ID: 8151325
[TBL] [Abstract][Full Text] [Related]
11. Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin.
Trigg ME; Morgan D; Burns TL; Kook H; Rumelhart SL; Holida MD; Giller RH
Bone Marrow Transplant; 1997 Jan; 19(1):43-7. PubMed ID: 9012930
[TBL] [Abstract][Full Text] [Related]
12. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.
Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR
Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
Iwen PC; Reed EC; Armitage JO; Bierman PJ; Kessinger A; Vose JM; Arneson MA; Winfield BA; Woods GL
Infect Control Hosp Epidemiol; 1993 Mar; 14(3):131-9. PubMed ID: 8478525
[TBL] [Abstract][Full Text] [Related]
14. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
Oren I; Haddad N; Finkelstein R; Rowe JM
Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
17. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B.
Singh N; Mieles L; Yu VL; Gayowski T
Clin Infect Dis; 1993 Nov; 17(5):906-8. PubMed ID: 8286639
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
Wingard JR; Kubilis P; Lee L; Yee G; White M; Walshe L; Bowden R; Anaissie E; Hiemenz J; Lister J
Clin Infect Dis; 1999 Dec; 29(6):1402-7. PubMed ID: 10585786
[TBL] [Abstract][Full Text] [Related]
19. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
20. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
